Workflow
JOUDER PRECISION(300549)
icon
Search documents
优德精密工业(昆山)股份有限公司 2025年度业绩预告
Performance Forecast - The company has voluntarily announced a performance forecast for the period from January 1, 2025, to December 31, 2025, indicating a projected decline in performance [1] - The company expects a year-on-year revenue decline of approximately 9% due to operational pressures in its main automotive mold components business [1] Reasons for Performance Change - The decline in revenue is attributed to increased procurement costs from imported raw materials due to tariff hikes, coupled with intensified competition in the domestic automotive mold components market, leading to reduced sales and revenue [1] - Although the medical device components and automation components segments experienced year-on-year growth, this growth was insufficient to offset the decline in the automotive mold components business, resulting in an overall decrease in performance [1] Financial Risk Management - The company is focusing on financial risk prevention by enhancing the management of accounts receivable, implementing a customer credit assessment mechanism, and strengthening the tracking of payment processes, with no significant bad debts reported during the period [2] Additional Information - The performance forecast is based on preliminary calculations by the company's finance department and has not yet been audited [3] - Detailed performance data for 2025 will be disclosed in the company's annual report for that year [3]
优德精密:2025年度业绩预告
Zheng Quan Ri Bao· 2026-01-23 12:17
(文章来源:证券日报) 证券日报网讯 1月23日,优德精密发布2025年度业绩预告称,公司预计2025年归属于上市公司股东的净 利润为720万元至920万元,比上年同期下降47.44%至32.84%。 ...
优德精密:2025年净利同比预降32.84%-47.44%
近年来市盈率变化情况(倍) 中证智能财讯优德精密(300549)1月23日晚间披露2025年度业绩预告,预计2025年营业收入同比下降9%;归母净利润720万元至920万元,同比下降 32.84%-47.44%;扣非净利润预计160万元-220万元,同比下降75.82%-82.42%。以1月23日收盘价计算,优德精密目前市盈率(TTM)约为292.77倍-374.09 倍,市净率(LF)约4.88倍,市销率(TTM)约8倍。 以本次披露业绩预告均值计算,公司近年市盈率(TTM)图如下所示: 制图数据来自恒生聚源数据库 350 @00 250 200 188.97 176.68 150 123.26 100 103.07 56 50 7-2- 25-96 0 2020-12-37 1 2021-12-37 022-72-3- 2n- - 公司 -{}- 行业均值 100 ହି ୨୦ 87c39 8202 80 70 60 65022 60 53b21 50 40 33983 30 30-3 30497 20 10 0 2027-12-37 ' 2020-12-37 -12-37 2-12-3- -06-> 2n ...
优德精密(300549.SZ)发预减,预计2025年度归母净利润720万元至920万元,同比下降32.84%至47.44%
智通财经网· 2026-01-23 09:41
智通财经APP讯,优德精密(300549.SZ)披露2025年度业绩预告,公司预计归属于上市公司股东的净利润 720万元至920万元,同比下降32.84%至47.44%;扣除非经常性损益后的净利润160万元至220万元,同比 下降75.82%至82.42%。 ...
优德精密(300549.SZ):预计2025年净利润同比下降32.84%-47.44%
Ge Long Hui A P P· 2026-01-23 09:22
1.本报告期内公司业绩同比下滑,本年度营业收入同比下滑约9%,核心系主营的汽车模具零部件业务 遭遇阶段性经营压力,对公司整体经营及财务指标形成影响。该业务中部分产品的原材料依赖进口,受 关税上调政策影响导致采购成本显著增加,叠加国内汽车模具零部件市场竞争日趋激烈的行业环境,双 重因素共同削弱了产品在国内市场的价格竞争力,最终引致该类产品销量下滑、营收降幅扩大,且该业 务营收降幅大于成本降幅,进一步导致公司整体盈利空间收窄、毛利率同比回落。2.尽管公司医疗器械 零部件、自动化零部件两大业务板块均实现同比增长,但增长贡献未能抵消汽车模具零部件业务的业绩 降幅,最终引致公司整体业绩同比下滑。3.面对阶段性经营压力,公司高度重视财务风险防控,持续深 化应收账款精细化管理,通过完善客户信用评估机制、强化回款全流程跟踪督办等举措,本报告期内未 发生重大坏账情形。 格隆汇1月23日丨优德精密(维权)(300549.SZ)公布,预计2025年归属于上市公司股东的净利润720万 元~920万元,比上年同期下降47.44%~32.84%,扣除非经常性损益后的净利润160万元~220万元,比 上年同期下降82.42%~75.82% ...
优德精密:2025年全年净利润同比预减32.84%—47.44%
Core Viewpoint - The company expects a significant decline in net profit for 2025, with projections indicating a decrease of 32.84% to 47.44% compared to the previous year, primarily due to challenges in its automotive mold components business [1] Financial Performance - The projected net profit attributable to shareholders for 2025 is estimated to be between 7.2 million and 9.2 million yuan [1] - The projected net profit after deducting non-recurring gains and losses is expected to be between 1.6 million and 2.2 million yuan, reflecting a year-on-year decrease of 75.82% to 82.42% [1] - The company's overall revenue is anticipated to decline by approximately 9% year-on-year [1] Business Segment Analysis - The automotive mold components business is facing significant operational pressure, which has adversely affected the company's overall performance and financial metrics [1] - The decline in sales and revenue for automotive mold components is attributed to increased procurement costs due to higher import tariffs and intensified competition in the domestic market [1] - Despite growth in the medical device components and automation components segments, the contributions from these areas were insufficient to offset the decline in the automotive mold components business [1] Risk Management - The company is focusing on financial risk prevention and has implemented measures to enhance accounts receivable management, including improving customer credit assessment and strengthening the tracking of payment processes [1] - There have been no significant bad debts reported during the reporting period, indicating effective risk management practices [1]
优德精密:预计2025年净利润同比下降47.44%~32.84%
Xin Lang Cai Jing· 2026-01-23 08:17
优德精密公告,预计2025年度净利润为720万元~920万元,同比下降47.44%~32.84%。本报告期内公 司业绩同比下滑,本年度营业收入同比下滑约9%,核心系主营的汽车模具零部件业务遭遇阶段性经营 压力,对公司整体经营及财务指标形成影响。该业务中部分产品的原材料依赖进口,受关税上调政策影 响导致采购成本显著增加,叠加国内汽车模具零部件市场竞争日趋激烈的行业环境,双重因素共同削弱 了产品在国内市场的价格竞争力,最终引致该类产品销量下滑、营收降幅扩大,且该业务营收降幅大于 成本降幅,进一步导致公司整体盈利空间收窄、毛利率同比回落。 ...
优德精密(300549) - 2025 Q4 - 年度业绩预告
2026-01-23 08:08
证券代码:300549 证券简称:优德精密 公告编号:2026-001 优德精密工业(昆山)股份有限公司 2025 年度业绩预告 本公司及董事会全体成员保证公告的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 2.业绩预告情况:自愿性业绩预告 单位:万元 | 项 | 目 | 本会计年度 | 上年同期 | | | --- | --- | --- | --- | --- | | 归属于上市公司 股东的净利润 | | 720~920 | | 1,369.87 | | | | 比上年同期下降:47.44%~32.84% | | | | 扣除非经常性损 | | 160~220 | | 909.99 | | 益后的净利润 | | 比上年同期下降:82.42%~75.82% | | | 二、与会计师事务所沟通情况 1.公司已就业绩预告相关事项与会计师事务所进行预先沟通,双方就本报告期业绩预告内容 不存在分歧意见; 2.本次业绩预告相关数据尚未经注册会计师审计。 三、业绩变动原因说明 1.本报告期内公司业绩同比下滑,本年度营业收入同比下滑约 9%,核心系主营的汽车模具 零部件业务遭遇阶段性经营压力,对公司整体经 ...
优德精密:公司已确定披露每月末的股东户数
Zheng Quan Ri Bao Wang· 2026-01-16 09:13
Group 1 - The company, Youde Precision (300549), has announced that it will disclose the number of shareholders at the end of each month for investor reference [1]
优德精密:公司部分产品为手术机器人配套专用手术器械,覆盖骨科、腔镜、神经外科等多类手术机器人适配器械
Mei Ri Jing Ji Xin Wen· 2026-01-15 01:33
Group 1 - The company offers surgical robot products that include specialized surgical instruments for various types of surgeries such as orthopedics, endoscopy, and neurosurgery, focusing on the demand for precision minimally invasive surgical instruments [2] - The primary customers are partners within the medical device industry supply chain, and specific client information is considered confidential commercial details [2]